Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts to improve standard interventions. As CRC patients can benefit from immunotherapeutic strategies that incite effector T cell action, cancer vaccines represent a safe and promising therapeutic approach to elic...
| Հիմնական հեղինակներ: | , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Taylor & Francis Group
2023-12-01
|
| Շարք: | OncoImmunology |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2260620 |